Table 3.
Hazard ratio (HR) and 95% CI of deatha
| Analysis before 3 years post‐surgery | Low VASH1 | Medium VASH1 | High VASH1 |
|---|---|---|---|
| All Periods | |||
| Person‐years | 123.0 | 125.7 | 157.1 |
| Death and recurrence rate (per 100 person‐years) | 9.8 | 10.3 | 3.2 |
| Crude HR (95% CI) | Ref | 1.08 (0.49‐2.36) | 0.34 (0.12‐0.96) |
| Multivariate adjusted HR (95% CI) | Ref | 1.11 (0.49‐2.52) | 0.37 (0.13‐1.08) |
| First 3 y After the Operation | |||
| Person‐years | 65.0 | 65.5 | 75.1 |
| Death and recurrence rate (per 100 person‐years) | 10.8 | 15.3 | 4.0 |
| Crude HR (95% CI) | Ref | 1.41 (0.54‐3.71) | 0.37 (0.096‐1.43) |
| Multivariate adjusted HR (95% CI) | Ref | 1.34 (0.44‐4.07) | 0.43 (0.11‐1.73) |
| More Than 3 y After the Operation | |||
| Person‐years | 58.0 | 60.2 | 82.0 |
| Death and recurrence rate (per 100 person‐years) | 8.6 | 5.0 | 2.4 |
| Crude HR (95% CI) | Ref | 0.61 (0.14‐2.53) | 0.29 (0.056‐1.49) |
| Multivariate adjusted HR (95% CI) | Ref | 0.54 (0.095‐3.03) | 0.27 (0.045‐1.63) |
Abbreviation: VASH1, vasohibin‐1.
a
Multivariate HR (95% CI) has been adjusted for age, sex, baseline performance status (0, 1, or more), and pathological stage (stages IA, IB, and IIA/IIB/IIIA).